Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August - September - Oktober - November - December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
- 2019
August 2019 - 38 products
CM
Sun Store Cetirizin
10
PR
PR
k.A.
Coated tablets: Cetirizini Dihydrochloridum 10 mg
Sun Store Health Care AG
D
FB
G
Procysbi 25 mg
60
PR
PR
k.A.
gélules gastro-résistantes: Mercaptaminum 25 mg
Chiesi SA
B
FB
G
Procysbi 75 mg
250
PR
PR
k.A.
gélules gastro-résistantes: Mercaptaminum 75 mg
Chiesi SA
B
FB
G
V/S
Vaxelis 0.5 ml
PR
PR
k.A.
Future Health Pharma
GmbH
B
FB
G
V/S
Vaxelis 0.5 ml
10
PR
PR
k.A.
Future Health Pharma
GmbH
B
FB
G
Pelgraz 6 mg/ 0.6 ml
PR
PR
k.A.
Injection solution in prefilled syringe: Pegfilgrastimum 6 mg
Accord Healthcare AG
A
FB
G
Monofer 100 mg / 1 ml
5 x 1 ml
PR
PR
k.A.
Solution for intravenous injection/infusion: Ferrum(iii) 100 mg/ml
Pierre Fabre Pharma SA
B
FB
G
Monofer 500 mg / 5 ml
5 ml
PR
PR
k.A.
Solution for intravenous injection/infusion: Ferrum(iii) 500mg / 5ml
Pierre Fabre Pharma SA
B
FB
G
Monofer 1000 mg / 10 ml
10 ml
PR
PR
k.A.
Solution for intravenous injection/infusion: Ferrum(iii) 1000mg / 10ml
Pierre Fabre Pharma SA
B
FB
G
Monofer 1000 mg / 10 ml
2 x 10 ml
PR
PR
k.A.
Solution for intravenous injection/infusion: Ferrum(iii) 1000mg / 10ml
Pierre Fabre Pharma SA
B
FB
G
Monofer 500 mg / 5 ml
5 x 5 ml
PR
PR
k.A.
Solution for intravenous injection/infusion: Ferrum(iii) 500mg / 5ml
Pierre Fabre Pharma SA
B
FB
G
Docetaxel Accord 20 mg/1 ml
PR
PR
k.A.
Concentrate for infusion: Docetaxelum 20 mg/ml
Accord Healthcare AG
A
FB
G
Docetaxel Accord 80 mg/4 ml
PR
PR
k.A.
Concentrate for infusion: Docetaxelum 80mg / 4ml
Accord Healthcare AG
A
FB
G
Docetaxel Accord 160 mg/8 ml
PR
PR
k.A.
Concentrate for infusion: Docetaxelum 160mg / 8ml
Accord Healthcare AG
A
FB
G
Desfesoterodin-Mepha
retard 3.5 mg
14 mg
PR
PR
k.A.
Delayed release tablets: Desfesoterodini Succinas 3.5 mg
Mepha Pharma AG
B
FB
G
Desfesoterodin-Mepha
retard 3.5 mg
84 mg
PR
PR
k.A.
Delayed release tablets: Desfesoterodini Succinas 3.5 mg
Mepha Pharma AG
B
FB
G
Desfesoterodin-Mepha
retard 7 mg
14 mg
PR
PR
k.A.
Delayed release tablets: Desfesoterodini Succinas 7 mg
Mepha Pharma AG
B
FB
G
Desfesoterodin-Mepha
retard 7 mg
84 mg
PR
PR
k.A.
Delayed release tablets: Desfesoterodini Succinas 7 mg
Mepha Pharma AG
B
FB
G
Fampyra 10 mg
56
PR
PR
k.A.
Delayed release tablets: Fampridinum 10 mg
Biogen Switzerland AG
B
FB
G
Duzallo 200 mg / 200 mg
30
PR
PR
k.A.
Coated tablets: 2 Active Agents
Grünenthal Pharma AG
B
FB
G
Duzallo 200 mg / 200 mg
100
PR
PR
k.A.
Coated tablets: 2 Active Agents
Grünenthal Pharma AG
B
FB
G
Duzallo 300 mg / 200 mg
30
PR
PR
k.A.
Coated tablets: 2 Active Agents
Grünenthal Pharma AG
B
FB
G
Duzallo 300 mg / 200 mg
100
PR
PR
k.A.
Coated tablets: 2 Active Agents
Grünenthal Pharma AG
B
FB
G
Efavirenz / Emtricitabin /
Tenofovirdisoproxil Mylan
30
PR
PR
k.A.
Coated tablets: 3 Active Agents
Mylan Pharma GmbH
B
FB
G
Prasugrel-Mepha 5 mg
30 mg
PR
PR
k.A.
Coated tablets: Prasugrelum 5 mg
Mepha Pharma AG
B
FB
G
Prasugrel-Mepha 5 mg
100 mg
PR
PR
k.A.
Coated tablets: Prasugrelum 5 mg
Mepha Pharma AG
B
FB
G
Prasugrel-Mepha 10 mg
30 mg
PR
PR
k.A.
Coated tablets: Prasugrelum 10 mg
Mepha Pharma AG
B
FB
G
Prasugrel-Mepha 10 mg
100 mg
PR
PR
k.A.
Coated tablets: Prasugrelum 10 mg
Mepha Pharma AG
B
FB
G
IP
CI
Vizimpro 15 mg
30
PR
PR
k.A.
Coated tablets: Dacomitinibum 15 mg
Pfizer AG
A
FB
G
IP
Vizimpro 30 mg
30
PR
PR
k.A.
Coated tablets: Dacomitinibum 30 mg
Pfizer AG
A
FB
G
IP
Vizimpro 45 mg
30
PR
PR
k.A.
Coated tablets: Dacomitinibum 45 mg
Pfizer AG
A
FB
G
CM
Gincosan
30
PR
PR
k.A.
Capsules: 2 Active Agents
Max Zeller Söhne AG
D
FB
G
CM
Gincosan
100
PR
PR
k.A.
Capsules: 2 Active Agents
Max Zeller Söhne AG
D
FB
G
CM
Prostatonin
60
PR
PR
k.A.
Capsules: 2 Active Agents
Max Zeller Söhne AG
D
FB
G
Rasagilin Mylan 1 mg
30
PR
PR
k.A.
Tablets: Rasagilinum 1 mg
Mylan Pharma GmbH
B
FB
G
Rasagilin Mylan 1 mg
100
PR
PR
k.A.
Tablets: Rasagilinum 1 mg
Mylan Pharma GmbH
B
FB
G
Saflutan
3 ml
PR
PR
k.A.
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B
FB
G
Saflutan
3 x 3 ml
PR
PR
k.A.
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT.(CHF, USD, EURO)
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT.(CHF, USD, EURO)
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2019
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
